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Abstract - The aim of the present study was to determine whether Interleukin (IL)-1β-mediated human embryonic pulmo-
nary fibroblast transdifferentiation could be reversed by targeting of the ERK signaling pathway. The human embryonic 
pulmonary fibroblast MRC-5 cell line was used as a model to observe IL-1β-mediated transdifferentiation as well and the 
inhibitory effects of lentinan (LNT). Cell proliferation was examined by a CCK-8 assay. ERK signaling activity was de-
tected using immunoblotting with phospho-ERK antibody. The expression levels of fibronectin (FN), Col I and α-smooth 
muscle actin (α-SMA) were assessed by either reverse transcription PCR or the SABC assay. IL-1β-induced-ERK signal-
ing activation in MRC-5 cells was inhibited by pretreatment with the LNT or ERK inhibitor U0126. IL-1β-enhanced cell 
proliferation and expression of FN, Col I and α-SMA were also attenuated by the treatment with LNT. Our study revealed 
that activation of ERK signaling is involved in IL-1β-mediated human embryonic pulmonary fibroblast proliferation, 
phenotypic switching and collagen secretion. These transdifferentiation events in MRC-5 cells could be reversed with LNT 
treatment by targeting the ERK signaling pathway 
Key words: Lentinan, ERK signaling, MRC-5 cell transdifferentiation, α-SMA
Abbreviations: IL – interleukin; LNT – lentinan; α-SMA – smooth muscle actin; HEPF – human embryonic pulmonary 
fibroblast; CCK-8 – Cell Counting Kit-8; Col- – collagen type ; ECM – extracellular matrix; EMTU – epithelial mesenchy-
mal trophic unit; ERK – external signal regulated kinase; FN – Fibronectin
INTRODUCTION
Asthma is a chronic airway disorder resulting from 
bronchial inflammation, which is characterized by 
bronchial hyperreactivity and airflow obstruction. 
As  the  primary  pathophysiological  characteristic 
of asthma, airway remodeling is defined based on 
histological  descriptions,  including  bronchial  wall 
thickening, subepithelial fibrosis, collagen basement 
membrane deposition, muscle cells hyperplasia or 
hypertrophy, goblet cell hyperplasia, mucus gland 
metaplasia or neovascularization formation (Giro-
det et al., 2011; Holgate et al., 2009). The pathological 
consequences of airway remodeling in asthma may 
include airway hyperreactivity, continuous airflow 
obstruction  and  irreversible  pulmonary  dysfunc-
tion (Elias et al., 1999). Alterations in structural cell 
function are one of the characteristic aspects of air-
way remodeling in asthma. During airway remod-
eling,  fibroblast-myofibroblast  transdifferentiation 
induced by chronic airflow inflammation may play 
an  important  role  in  extracellular  matrix  (ECM) 
deposition  of  the  basement  membrane,  resulting 
in subepithelial reticular layer thickening, luminal 820 LONG-TENG JIN ET AL.
stenosis and airway remodeling (Homer and Elias, 
2005).
IL-1β  is  a  widely  recognized  multifunctional 
cellular inflammatory factor and plays central roles 
in  initiating  an  inflammation  reaction  (Dinarello, 
2011). As reported, bronchial lavage fluid collected 
from asthmatic patients has a high concentration of 
IL-1β that may underlie an etiology of asthma (Hori-
ba et al., 2011). Although functions of IL-1β are ex-
tensively studied in acute inflammation, its roles in 
chronic continuous airway inflammation have not 
been well defined. 
Lentinan  (LNT),  a  purified  β-glucan  isolated 
from the fruit body of shiitake (Lentinula edodes) has 
a variety of bioactivities, such as activation of the im-
mune system, inhibition of proliferation and migra-
tion of tumor cells, and modulation of fat and carbo-
hydrate metabolism (Rop et al., 2009). Furthermore, 
a  previous  study  revealed  that  LNT  could  inhibit 
IL-1β-induced  fibroblast  transdifferentiation  (Jin 
et al., 2011). To gain a better understanding of the 
molecular mechanisms underlying cell signaling in 
airway remodeling, we used MRC-5 cells as a model 
to clarify the roles of IL-1β in human embryonic pul-
monary fibroblast transdifferentiation. Considering 
that IL-1β is an important extracellular external sig-
nal regulated kinase (ERK) modulator (Jiang et al., 
2004), we also determined whether IL-1β-mediated 
human  embryonic  pulmonary  fibroblast  transdif-
ferentiation could be reversed by targeting the ERK 
signaling pathway.
MATERIALS AND METHODS
Cell culture and drug treatment
The human embryonic pulmonary fibroblast MRC-
5 cell line was obtained from the American Type 
Culture Collection (fourth generation). Cells were 
cultured  in  Dulbecco’s  modified  Eagle’s  medium 
(DMEM, Gibco, USA), supplied with 10% fetal bo-
vine serum (Gibco, USA), 100 U/ml penicillin and 
100 mg/ml streptomycin with a humidified atmos-
phere of 5% CO2 at 37°C. During the 7th-15th pas-
sages, cells at 80% confluence were starved of se-
rum for 24 h. To observe the effect of IL-1β on ERK 
activation, starved cells were stimulated with IL-1β 
(R&D, USA) at a concentration of 10 ng/mL for 1 
min, 15 min, 30 min, 1 h, 2 h and 4 h, respectively. 
To further verify the dose-dependent effect of IL-
1β, starved cells were treated with IL-1β at doses 
of 0.1 ng/ml, 1 ng/ml, 5 ng/ml and 10 ng/ml for 1 
h, respectively. Moreover, starved cells were divided 
into four groups to investigate the effect of LNT on 
IL-1β-induced proliferation and other related func-
tions. The groups included: (a) control group, (b) 
IL-1β group (10 ng/mL IL-1β), (c) LNT (Nanjing 
Kanghai Pharmacy) group (pretreatment with 4 μg/
mL LNT for 1h, followed by 10 ng/mL IL-1β treat-
ment); (d) U0126 (CST, USA) group (10 μM U0126 
pretreatment with 10 μM U0126 for 1h, followed by 
10 ng/mL IL-1β treatment). Cell lysates or mRNA 
extracts  were  prepared  for  Western  immunoblot 
or RT-PCR at the indicated times (48 h following 
IL-1β treatment for the expression level of protein 
or mRNA of α-smooth muscle actin (α-SMA), Fi-
bronectin (FN), and Col I).
Western immunoblotting
Following treatment with drugs, total proteins were 
extracted  and  the  protein  level  was  measured  us-
ing a bicinchoninic acid (BCA) protein assay. Equal 
amounts of protein extracts were then separated us-
ing 10% sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE), transferred to polyvi-
nylidene fluoride (PVDF) membranes, and blocked 
with 5% non-fat dried milk in phosphate buffered 
saline (PBS) for 1 h. The membranes were incubated 
with anti-ERK1/2 (1:1000, CST, USA) and anti-p-
ERK1/2 (1:1000, CST, USA) overnight at 4oC. After 
washing with TBST (10 mM Tris-HCl, pH 7.4, 150 
mM NaCl, 0.05% Tween-20), the membranes were 
incubated  with  a  horseradish  peroxidase  (HRP)-
labeled secondary antibody (1:300) at RT for 2 h. 
Signals were visualized using an enhanced chemilu-
minescence detection kit. Densitometric values were 
semiquantified using Gel-Pro Analyzer 3.1. The val-
ues from the treatment groups were normalized to 
the control group.REVERSE HEPF TRANSDIFFERENTIATION AND ERK 821
Cell proliferation
Cell viability was determined using a CCK-8 assay 
(Dojindo Molecular Technologies, Inc. Japan). 10 ul 
of CCK-8 assay reagent was added into each well and 
incubated for 1 h in 5% CO2 and 370C. Optical den-
sity values were measured using an automatic ELISA 
reader (BioTek Instruments, USA) at a wavelength 
of 450 nm.
SABC assay
Cells were seeded onto the cover glasses until fully 
attached to the surface and then treated with drugs 
at the indicated time. The treated cells were fixed 
with 4% paraformaldehyde (PFA), followed by im-
munohistochemical staining using an SABC assay, 
according  to  manufacturer’s  instruction.  α-SAM 
antibody (Abcam, UK) was used at 1:200 dilution 
in  the  SABC  assay.  The  cells  with  brown-yellow 
deposition in the cytoplasm were considered to be 
positively stained. Four fields in each image were 
analyzed. The expression level of protein was meas-
ured as mean optical density (MOD) using Image-
pro plus software.
Semi-quantitative Polymerase Chain  
Reaction (PCR)
Total RNA was isolated using Trizol Reagent (Inv-
itrogen, USA) according to the manufacturer’s in-
structions. RNA was then reverse-transcribed in a 
reaction using a reverse-transcription system (Bei-
jing Tiangen, China). The cycle parameters for the 
PCR reaction were an initial hold at 94 °C for 3 min, 
followed by 20 cycles at 94°C for 30 s and appropri-
ate annealing temperature (FN at 57oC, Col I at 63oC, 
and α-SAM at 60oC) for 30 s, and finally at 72°C for 
5 min. Amplification of β-actin was under the same 
conditions of PCR for its corresponding target gene. 
The specific primers used for PCR were synthesized 
at  Shenggong  Company  (Shanghai)  and  are  listed 
in Table 1. PCR products were analyzed using Gel-
Pro Analyzer 3.1. Changes in the expression of tar-
get genes were determined using a ratio of target to 
β-actin following normalization.
Statistical Analyses
The data were analyzed using SPSS 13.0 software. The 
values are presented as mean ± standard deviation 
(SD) from three independent experiments. One-way 
analysis of variance (ANOVA) was used for testing 
differences among two or more independent groups 
followed by a LSD (least significant difference) or 
Tamhane’s T2. P <0.05 was considered statistically 
significant.
RESULTS
IL-1β-induced activation of ERK signaling
Since IL-1β is an important regulator of the ERK sig-
naling pathway, we first investigated the effect of IL-
1β on ERK signaling activation in MRC-5 cells using 
western  immunoblotting.  The  results  showed  that 
Fig. 1. IL-1β (10 ng/mL) induced a progressive increase of p-
ERK level, followed by decrease to the control level 4 h later. 
Compared with control, **P<0.01.822 LONG-TENG JIN ET AL.
IL-1β (10 ng/mL) induced a significant increase in 
phosphorylation of ERK following 15 min of stimu-
lation, as compared to the control group (Fig. 1). The 
level of p-ERK reached a peak around 1 h following 
IL-1β treatment and decreased to the basal level af-
ter 4 h treatment. Next, we validated the dose-de-
pendent effects of IL-1β on ERK signaling activation 
and found that treatment with 10 ng/ml IL-1β for 1 
h could induce a 6-fold increase in p-ERK levels, as 
compared to control (Fig. 2).
The effect of LNT on ERK phosphorylation
To identify the effect of LNT on IL-1β-induced ERK 
activation, we observed the p-ERK1/2 level in the 
LNT group. As shown in Fig. 3, the values of normal-
ized p-ERK1/2 (value in the control group was 1.0) 
were 6.367±0.104 in the IL-1β group, 1.220±0.069 
in the LNT group (4 μg/ml) and 1.381±0.054 in the 
U0126  group  (10  μM).  These  data  suggested  that 
LNT could significantly inhibit IL-1β-induced ERK 
Fig.  2.  IL-1β  induced  a  concentration-dependent  increase  in 
ERK activation. Compared with the control, **P<0.01.
Fig. 3. LNT (4 μg/mL) inhibited IL-1β-induced ERK phosphory-
lation. Compared with the IL-1β group, **P<0.01; compared with 
the control group, ##P<0.01.
Fig. 4. LNT (4 μg/mL) inhibited IL-1β-induced cell prolifera-
tion. Compared with the IL-1β group, **P<0.01; compared with 
the control group, ##P<0.01.REVERSE HEPF TRANSDIFFERENTIATION AND ERK 823
activation (P<0.01). The inhibitory effect of LNT on 
IL-1β-induced ERK activation in MRC-5 cells was 
also  confirmed  using  a  comparison  of  U0126,  an 
MEK inhibitor (Fig. 3).
Effect of LNT on IL-1β-induced cell proliferation
Next we examined the effect of IL-1β on MRC-5 cell 
proliferation. Data using the CCK-8 assay revealed 
that the treatment with IL-1β for 48 h significantly 
promoted cell proliferation, as compared to the con-
trol group (Fig. 4). Pretreatment with LNT (4 μg/mL 
LNT) or U0126 (10 μM) attenuated IL-1β-induced 
cell proliferation. However, no significant differences 
were observed between the LNT and U0126 groups 
(P>0.05).
Fig. 5. LNT (4 μg/mL) inhibited IL-1β-induced α-SAM expression. Representative images of each group were with a magnification 400 
X. Scale bar: 5 μm. Compared with the IL-1β group, *P<0.05, **P<0.01; compared with the control group, ##P<0.01.824 LONG-TENG JIN ET AL.
Effect of LNT on IL-1β induced  
0fibroblast-to-myofibroblast transdifferentiation
To identify fibroblast-to-myofibroblast transdifferen-
tiation, the detection of α-SMA expression was per-
formed using an SABC assay, in which the positive 
cells present brown-yellow deposition located in the 
cytoplasm. Compared with the control group, higher 
levels of α-SMA expression were found in the IL-1β 
group (Fig. 5). The results shown in Fig. 5 demonstrat-
ed that IL-1β treatment significantly increased α-SMA 
expression. IL-1β-induced fibroblast-to-myofibroblast 
transdifferentiation in MRC-5 cells could be inhibited 
by either LNT or U0126 pretreatment, implying a re-
versal of IL-1β-mediated transdifferentiation by tar-
geting the ERK signaling pathway (Fig. 5).
Fig. 6. LNT (4 μg/mL) inhibited IL-1β-induced FN expression (A), Col I expression (B) and α-SAM expression (C). Compared with the 
IL-1β group, *P<0.05, ** P<0.01; compared with the control group, ##P<0.01.
Table 1. Primer sequences for PCR 
   Name           Primer sequence Number of bases
    FN  forward
   FN  reverse
  Col I   forward
TAGCCCTGTCCAGGAGTTCA
CTGCAAGCCTTCAATAGTCA
GTCTTCCTGGCCCCTCTGGTG
346
391
 Col I   reverse TCGCCCTGTTCGCCTGTCTCA
α-SAM  forward
        reverse
β-actin   forward
        reverse
GCGTGGCTATTCCTTCGTTAC
CATAGTGGTGCCCCCTGATAG
CCTTCCTGGGCATGGAGTCCT
GGAGCAATGATCTTGATCTT
331
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mRNA expression of FN, Col I and α-SAM
To study the correlation of either FN or Col I and 
α-SAM, we assessed the mRNA of these molecules by 
RT-PCR. As shown in Figs. 6A, 6B and 6C, compared 
with the control IL-1β induced a significant increase 
in mRNA levels of FN, Col I and α-SAM (P<0.01). 
Furthermore, the IL-1β-induced expression of FN, 
Col I and α-SAM was attenuated by pretreatment 
with either LNT or U0126 (Fig. 6), consistent with 
the inhibition of IL-1β-induced α-SAM protein ex-
pression using LNT or U0126, as shown in Fig. 5.
DISCUSSION
The mechanisms underlying the pathological chang-
es associated with asthma remain poorly understood. 
Structural changes in airway remodeling are thought 
to be secondary phenomena elicited by inflammation 
in the asthma airway (Fahy et al., 2000). However, a 
recent study suggested that airway remodeling was 
parallel to airway inflammation during asthma or 
even an elicited continuous airway inflammation re-
action (Jin et al., 2011). With asthma, the airway epi-
thelium is more vulnerable to environmental injury 
and responds to this by impaired healing. However, 
the relationship to an altered structure and function 
of the airways is largely unknown.
Holgate et al. (2000) proposed a model of epi-
thelial-mesenchymal communication in the patho-
genesis of chronic asthma. In their model, a fiber cell 
layer, located under the basement membrane of the 
airway is involved in a functional communication 
network of epithelium, nerve tissue and extracellu-
lar matrix, which is termed the epithelial mesenchy-
mal trophic unit (EMTU). Normally, EMTU is in a 
stationary state following airway maturation during 
lung development. When exposed to environmental 
risk factors, EMTU is activated and the susceptible 
cell populations produce cytokines and growth fac-
tors, such as transforming growth factor-β (TGF-β) 
and epidermal growth factor (EGF). Activation of 
EMTU is involved in communication between the 
damaged and stressed epithelium and the underly-
ing fibroblast sheath. Meanwhile, TGF-β production 
promotes the underlying fibroblasts to differentiate 
into myofibroblasts that can synthesize more colla-
gen and extracellular matrix components. The active 
myofibroblasts will release ET1, vascular endothelial 
growth factor and collagen, finally resulting in air-
way  remodeling  and  inflammation  (Knight  et  al., 
2004; Holgate et al., 2006).
IL-1β is a multifunctional cellular factor, play-
ing central roles in initiating the inflammation. IL-
1β can activate lymphocytes and speed cell adhesion 
and chemotaxis around the inflammatory region, es-
pecially associated with the release of inflammatory 
mediators (Dinarello, 2000). Lin et al. (2008) reported 
that in asthmatic rats, IL-1β levels in the serum and 
lavage fluid were increased, contributing to airway 
remodeling by activating the JNK signaling pathway. 
Lappalainen et al. (2005) revealed that in respira-
tory epithelial cells of adult mice, an accumulation 
of MMP-9 and MMP-12 induced by chronic produc-
tion of IL-1β could cause lung inflammation, distal 
airspace enlargement, mucus metaplasia and airway 
fibrosis. These data implied that IL-1β might be a po-
tent inducer of asthma. Therefore, our present study 
focused on IL-1β-mediated human embryonic pul-
monary fibroblast transdifferentiation. We selected 
MRC-5 cells as a model to investigate IL-1β-induced 
fibroblast-to-myofibroblast  transdifferentiation  in 
this study. We expect our findings may address the 
mechanisms underlying asthma pathogenesis, lead-
ing to the discovery of novel therapeutic drugs.
Myofibroblasts  were  characterized  using  high 
expression of α-SMA as one of the markers in dis-
tinguishing the differentiation status of myofibrob-
lasts. As one of the components of ECM, Col I is se-
creted by fibroblasts. Thus, the measurement of Col 
I is often used for monitoring ECM deposition level. 
Fibronectin can combine to specific receptors, such 
as  the  integrin  receptor  and  growth  factor  recep-
tor, involved in activating MAPK or other signaling 
pathways  to  induce  inflammation  cellular  growth, 
migration and differentiation, speeding ECM depo-
sition and initiating airway remodeling (Knight et al., 
2004). In our study, we observed that treatment with 
IL-1β at a dose of 10 ng/mL for 48 h, significantly 826 LONG-TENG JIN ET AL.
promoted MRC-5 cell proliferation with increased 
expression of α-SAM, FN and Col I. These data in-
dicated  that  transdifferentiation  from  pulmonary 
fibroblasts to myofibroblasts could be induced by IL-
1β. Additionally, IL-1β-induced upregulation of FN 
and Col I expressions might reflect a production of 
more collagen or ECM deposition that are potential 
contributors to asthma airway remodeling.
The ERK signaling pathway plays a critical role 
in  chronic  asthma  airway  inflammation,  hyperre-
sponsiveness,  especially  airway  remodeling  (Duan 
et al., 2004; Zhang et al., 2004). Our previous study 
demonstrated that the p-ERK level in the lungs of 
asthmatic rats was significantly increased and posi-
tively correlated with total bronchial wall thickness 
and smooth muscle thickness (Guan et al., 2007). In 
this study, we found that IL-1β induced a significant 
increase  in  phosphorylation  of  ERK  following  15 
min treatment in MRC-5 cells. The level of p-ERK 
reached a peak around 1 h following IL-1β treatment 
and decreased to basal levels after 4 h treatment. In 
addition, IL-1β induced ERK activation in a dose-
dependent manner. Treatment with 10 ng/ml IL-1β 
for 1 h could induce a six-fold increase in p-ERK lev-
el, as compared to that of the control. Furthermore, 
we confirmed that IL-1β-mediated fibroblast-to-my-
ofibroblasts transdifferentiation could be reversed by 
targeting the ERK signaling pathway, using the ERK 
inhibitor U0126.
As  a  T  lymphocyte-specific  immune  adjuvant, 
lentinan (LNT) plays a critical role in immune regu-
lation (Matsuoka et al., 1997). Our recent study re-
ported  that  LNT  could  inhibit  IL-1β-induced  cell 
proliferation  as  well  as  the  expression  of  α-SAM, 
FN and Col I (Jin et al., 2011). In this study, we ob-
served that LNT has a similar effect to U0126 in the 
inhibition of IL-1β-mediated ERK phosphorylation, 
cell proliferation, and the expression of FN, Col I 
and α-SMA. These data might imply that LNT may 
have the ability to affect lung fibroblast function, in-
cluding cell proliferation, phenotypic switching, and 
ECM deposition, even in asthma airway remodeling, 
by inhibiting ERK signaling activation.
In conclusion, herein we report that ERK signal-
ing activation is involved in IL-1β-mediated human 
embryonic  pulmonary  fibroblast  transdifferentia-
tion, phenotypic switching and collagen secretion in 
MRC-5 cells. These events can be reversed by target-
ing the ERK signaling pathway using the ERK in-
hibitor or LNT. This suggests that LNT is a potential 
agent capable of preventing IL-1β-mediated asthma 
airway remodeling.
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